Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
Clinical trial NCT06223958 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06223958
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2026-04-29
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.